BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28756911)

  • 1. The Current Status of Molecular Xenomonitoring for Lymphatic Filariasis and Onchocerciasis.
    Pilotte N; Unnasch TR; Williams SA
    Trends Parasitol; 2017 Oct; 33(10):788-798. PubMed ID: 28756911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of the eradicability of filarial infections: a conceptual approach.
    Duerr HP; Dietz K; Eichner M
    Trends Parasitol; 2005 Feb; 21(2):88-96. PubMed ID: 15664532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of traps and lures for mosquito vectors and xenomonitoring of Wuchereria bancrofti infection in a high prevalence Samoan Village.
    Hapairai LK; Plichart C; Naseri T; Silva U; Tesimale L; Pemita P; Bossin HC; Burkot TR; Ritchie SA; Graves PM; Melrose W; Joseph H
    Parasit Vectors; 2015 May; 8():287. PubMed ID: 26016830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. For as Long as Necessary: Examining 30 years of MSD's Focus on Achieving Elimination of Onchocerciasis and Lymphatic Filariasis.
    Gustavsen KM; Colatrella BD; McCoy T
    Int Health; 2018 Mar; 10(suppl_1):i3-i6. PubMed ID: 29186497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loa loa vectors Chrysops spp.: perspectives on research, distribution, bionomics, and implications for elimination of lymphatic filariasis and onchocerciasis.
    Kelly-Hope L; Paulo R; Thomas B; Brito M; Unnasch TR; Molyneux D
    Parasit Vectors; 2017 Apr; 10(1):172. PubMed ID: 28381279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospects, drawbacks and future needs of xenomonitoring for the endpoint evaluation of lymphatic filariasis elimination programs in Africa.
    Okorie PN; de Souza DK
    Trans R Soc Trop Med Hyg; 2016 Feb; 110(2):90-7. PubMed ID: 26822601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphatic filariasis and onchocerciasis prevention, treatment, and control costs across diverse settings: a systematic review.
    Keating J; Yukich JO; Mollenkopf S; Tediosi F
    Acta Trop; 2014 Jul; 135():86-95. PubMed ID: 24699086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of monitoring mosquito infection in the Global Programme to Eliminate Lymphatic Filariasis.
    Pedersen EM; Stolk WA; Laney SJ; Michael E
    Trends Parasitol; 2009 Jul; 25(7):319-27. PubMed ID: 19559649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphatic filariasis elimination and schistosomiasis control in combination with onchocerciasis control in Nigeria.
    Hopkins DR; Eigege A; Miri ES; Gontor I; Ogah G; Umaru J; Gwomkudu CC; Mathai W; Jinadu M; Amadiegwu S; Oyenekan OK; Korve K; Richards FO
    Am J Trop Med Hyg; 2002 Sep; 67(3):266-72. PubMed ID: 12408665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantifying filariasis and malaria control activities in relation to lymphatic filariasis elimination: a multiple intervention score map (MISM) for Malawi.
    Stanton MC; Mkwanda S; Mzilahowa T; Bockarie MJ; Kelly-Hope LA
    Trop Med Int Health; 2014 Feb; 19(2):224-35. PubMed ID: 24438053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the diagnostic test accuracy of molecular xenomonitoring methods for characterising the community burden of Onchocerciasis.
    Pryce J; Unnasch TR; Reimer LJ
    PLoS Negl Trop Dis; 2021 Oct; 15(10):e0009812. PubMed ID: 34637436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intervention research on onchocerciasis and lymphatic filariasis.
    Wkly Epidemiol Rec; 2000 Jul; 75(30):246-8. PubMed ID: 10946596
    [No Abstract]   [Full Text] [Related]  

  • 13. Filaria control and elimination: diagnostic, monitoring and surveillance needs.
    Molyneux DH
    Trans R Soc Trop Med Hyg; 2009 Apr; 103(4):338-41. PubMed ID: 19181357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Geographic and ecologic heterogeneity in elimination thresholds for the major vector-borne helminthic disease, lymphatic filariasis.
    Gambhir M; Bockarie M; Tisch D; Kazura J; Remais J; Spear R; Michael E
    BMC Biol; 2010 Mar; 8():22. PubMed ID: 20236528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphatic filariasis and onchocerciasis.
    Taylor MJ; Hoerauf A; Bockarie M
    Lancet; 2010 Oct; 376(9747):1175-85. PubMed ID: 20739055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onchocerciasis and lymphatic filariasis elimination in Africa: it's about time.
    Evans DS; Unnasch TR; Richards FO
    Lancet; 2015 May; 385(9983):2151-2. PubMed ID: 26068266
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessment and monitoring of onchocerciasis in Latin America.
    Rodríguez-Pérez MA; Unnasch TR; Real-Najarro O
    Adv Parasitol; 2011; 77():175-226. PubMed ID: 22137585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the Diagnostic Test Accuracy of Molecular Xenomonitoring Methods for Characterizing Community Burden of Lymphatic Filariasis.
    Pryce J; Reimer LJ
    Clin Infect Dis; 2021 Jun; 72(Suppl 3):S203-S209. PubMed ID: 33906238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urban lymphatic filariasis in central Nigeria.
    Terranella A; Eigiege A; Gontor I; Dagwa P; Damishi S; Miri E; Blackburn B; McFarland D; Zingeser J; Jinadu MY; Richards FO
    Ann Trop Med Parasitol; 2006 Mar; 100(2):163-72. PubMed ID: 16492364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short communication: impact of long-term (14 years) bi-annual ivermectin treatment on Wuchereria bancrofti microfilaraemia.
    Kyelem D; Medlock J; Sanou S; Bonkoungou M; Boatin B; Molyneux DH
    Trop Med Int Health; 2005 Oct; 10(10):1002-4. PubMed ID: 16185234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.